Merck & Co., Inc.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
Director
Phantom Stock
Derivative security · not the ordinary share price.
Director
Phantom Stock
Derivative security · not the ordinary share price.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Director
Phantom Stock
Derivative security · not the ordinary share price.
EVP, Access, Policy & Comms
Common Stock
EVP, General Counsel
Common Stock
EVP, General Counsel
Common Stock
EVP, General Counsel
Common Stock
EVP, General Counsel
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, General Counsel
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP&Pres, Merck Animal Heallth
Common Stock
EVP&Pres, Merck Animal Heallth
Common Stock
EVP&Pres, Merck Animal Heallth
Common Stock
EVP&Pres, Merck Animal Heallth
Common Stock
EVP&Pres, Merck Animal Heallth
Common Stock
EVP&Pres, Merck Animal Heallth
Common Stock
EVP&Pres, Merck Animal Heallth
Common Stock
EVP&Pres, Merck Animal Heallth
Common Stock
EVP & Pres. MMD
Common Stock
EVP & Pres. MMD
Common Stock
EVP & Pres. MMD
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Phantom StockGrant or award | Derivative units56$145.31 / derivative unit | $8.12K | Sep 30Filed Oct 1 · 1d later | SEC filing |
| Director | Phantom StockGrant or award | Derivative units112$145.31 / derivative unit | $16.25K | Sep 30Filed Oct 1 · 1d later | SEC filing |
| Director | Phantom StockGrant or award | Derivative units206$145.31 / derivative unit | $30K | Sep 30Filed Oct 1 · 1d later | SEC filing |
| EVP, Access, Policy & Comms | Common StockSale | 10,000$135.00 / share | $1.35M | Aug 13Filed Aug 13 · 0d later | SEC filing |
| EVP, General Counsel | Common StockOption exercise or conversion | 41,494$117.89 / share | $4.89M | Aug 12Filed Aug 13 · 1d later | SEC filing |
| EVP, General Counsel | Common StockOption exercise or conversion | 13,433$84.71 / share | $1.14M | Aug 12Filed Aug 13 · 1d later | SEC filing |
| EVP, General Counsel | Common StockSale | 80,315$133.46 / share | $10.72M | Aug 12Filed Aug 13 · 1d later | SEC filing |
| EVP, General Counsel | Stock Option (Right to Buy)Option exercise or conversion | Derivative units41,494$117.89 exercise / conversion price | Not a separate purchase | Aug 12Filed Aug 13 · 1d later | SEC filing |
| EVP, General Counsel | Stock Option (Right to Buy)Option exercise or conversion | Derivative units13,433$84.71 exercise / conversion price | Not a separate purchase | Aug 12Filed Aug 13 · 1d later | SEC filing |
| EVP&Pres, Merck Animal Heallth | Common StockSale | 20,784$130.43 / share | $2.71M | Aug 10Filed Aug 12 · 2d later | SEC filing |
| EVP&Pres, Merck Animal Heallth | Common StockSale2 trades | 12,837avg $131.76 / share | $1.69M | Aug 11Filed Aug 12 · 1d later | 2 filings
|
| EVP&Pres, Merck Animal Heallth | Common StockSale2 trades | 11,699avg $131.63 / share | $1.54M | Aug 12Filed Aug 12 · 0d later | 2 filings
|
| EVP&Pres, Merck Animal Heallth | Common StockSale3 trades | 6,050avg $130.38 / share | $788.77K | Aug 6Filed Aug 10 · 4d later | 3 filings
|
| EVP & Pres. MMD | Common StockOption exercise or conversion | 6,311$73.73 / share | $465.31K | Aug 5Filed Aug 7 · 2d later | SEC filing |
| EVP & Pres. MMD | Common StockSale | 6,311$128.72 / share | $812.34K | Aug 5Filed Aug 7 · 2d later | SEC filing |
| EVP & Pres. MMD | Common StockOption exercise or conversion | 9,709$87.10 / share | $845.65K | Aug 5Filed Aug 7 · 2d later | SEC filing |
Showing the latest 20 of 124 trades. Show all 124 trades
Merck & Company, Inc. Common Stock (MRK) · Stock
The filing reports a purchase for the member.
Maria Elvira SalazarReporting House memberMerck & Company, Inc. Common Stock (MRK) · Stock
The filing reports a purchase for the member.
Maria Elvira SalazarReporting House memberMerck & Company, Inc. Common Stock (new) · Stock
The filing reports a full sale for the member.
Merck & Company, Inc. Common Stock (MRK) · Stock
The filing reports a purchase for a joint account.
Josh GottheimerReporting House memberMerck & Company, Inc. Common Stock (MRK) · Stock
The filing reports a sale for a joint account.
Julie JohnsonReporting House memberMerck & Company, Inc. Common Stock (MRK) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberMerck & Company, Inc. Common Stock (MRK) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberMerck & Company, Inc. Common Stock (MRK) · Stock
The filing reports a partial sale for a joint account.
Julie JohnsonReporting House memberMerck & Company, Inc. Common Stock (MRK) · Stock
The filing reports a sale for a spouse.
Valerie HoyleReporting House memberMerck & Company, Inc. Common Stock (MRK) · Stock
The filing reports a sale for a spouse.
Sheri BiggsReporting House member